ADAR1 Capital Management, LLC 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 7:39 pm Sale | 2025-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | ADAR1 Capital Management, LLC | 2,962 0.100% | -119,862 (-97.59%) | Filing |
| 2024-11-14 4:47 pm Purchase | 2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB | ADAR1 Capital Management, LLC | 122,824 8.510% | 122,824 (New Position) | Filing |